ad image

Proof-of-Concept Trial

1 / 1
Expediting Radioimmune Conjugate Pharmaceuticals for First-In-Human Phase 0 Proof-of-Concept Human Studies from Stable Pool
Radioconjugate development

Expediting Radioimmune Conjugate Pharmaceuticals for First-In-Human Phase 0 Proof-of-Concept Human Studies from Stable Pool

Muctarr Sesay, Ph.D.; Natalia Bourguignon, Ph.D.

GBI

PAO-03-24-CL-07Mar 15, 2024
Gilead and Novo Nordisk Present New Data from Proof-of-Concept Trial in NASH
Proof-of-Concept Trial

Gilead and Novo Nordisk Present New Data from Proof-of-Concept Trial in NASH

PR-M11-20-014Nov 18, 2020
1 / 1